XML 15 R6.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN TOTAL EQUITY (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Capital in Excess of Stated Value
Accumulated Other Comprehensive Income/(Loss)
Retained Earnings
Noncontrolling Interests
Beginning balance at Dec. 31, 2023 $ 2,431,835 $ 7,175 $ 159,047 $ (366,262) $ 2,624,380 $ 7,495
Beginning balance (in shares) at Dec. 31, 2023   97,957        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 65,273       65,177 96
Other comprehensive (loss)/income            
Translation gain/(loss) (19,786)     (19,319)   (467)
Defined benefit plan adjustment, net of tax 43     43    
Derivative financial instruments, net of tax 169     169    
Other comprehensive (loss)/income (19,574)     (19,107)   (467)
Dividends (50,348)       (50,348)  
Issuance of stock awards 204   204      
Issuance of stock awards (in shares)   460        
Shares repurchased (9,139)   (9,139)      
Shares repurchased (in shares)   (162)        
Share-based compensation 8,325   8,325      
Other 906   906      
Ending balance at Mar. 31, 2024 2,427,482 $ 7,175 159,343 (385,369) 2,639,209 7,124
Ending balance (in shares) at Mar. 31, 2024   98,255        
Beginning balance at Dec. 31, 2023 2,431,835 $ 7,175 159,047 (366,262) 2,624,380 7,495
Beginning balance (in shares) at Dec. 31, 2023   97,957        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 207,433          
Other comprehensive (loss)/income            
Translation gain/(loss) (17,272)          
Defined benefit plan adjustment, net of tax 3,158          
Derivative financial instruments, net of tax (1,432)          
Other comprehensive (loss)/income (15,546)     (15,748)    
Ending balance at Sep. 29, 2024 2,487,160 $ 7,175 175,532 (382,010) 2,678,242 8,221
Ending balance (in shares) at Sep. 29, 2024   98,258        
Beginning balance at Dec. 31, 2023 2,431,835 $ 7,175 159,047 (366,262) 2,624,380 7,495
Beginning balance (in shares) at Dec. 31, 2023   97,957        
Ending balance at Dec. 31, 2024 $ 2,286,213 [1] $ 7,175 183,250 (502,734) 2,583,923 14,599
Ending balance (in shares) at Dec. 31, 2024 98,260 98,260        
Beginning balance at Mar. 31, 2024 $ 2,427,482 $ 7,175 159,343 (385,369) 2,639,209 7,124
Beginning balance (in shares) at Mar. 31, 2024   98,255        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 90,951       90,811 140
Other comprehensive (loss)/income            
Translation gain/(loss) (33,408)     (33,366)   (42)
Defined benefit plan adjustment, net of tax 2,079     2,079    
Derivative financial instruments, net of tax (1,661)     (1,661)    
Other comprehensive (loss)/income (32,990)     (32,948)   (42)
Dividends (51,347)       (51,347)  
Issuance of stock awards 181   181      
Issuance of stock awards (in shares)   4        
Shares repurchased (23)   (23)      
Shares repurchased (in shares)   (1)        
Share-based compensation 6,656   6,656      
Other 957   957      
Ending balance at Jun. 30, 2024 2,441,867 $ 7,175 167,114 (418,317) 2,678,673 7,222
Ending balance (in shares) at Jun. 30, 2024   98,258        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 51,209       50,921 288
Other comprehensive (loss)/income            
Translation gain/(loss) 35,922     35,211   711
Defined benefit plan adjustment, net of tax 1,036     1,036    
Derivative financial instruments, net of tax 60     60    
Other comprehensive (loss)/income 37,018     36,307   711
Dividends (51,352)       (51,352)  
Issuance of stock awards 265   265      
Shares repurchased (10)   (10)      
Share-based compensation 7,682   7,682      
Other 481   481      
Ending balance at Sep. 29, 2024 2,487,160 $ 7,175 175,532 (382,010) 2,678,242 8,221
Ending balance (in shares) at Sep. 29, 2024   98,258        
Beginning balance at Dec. 31, 2024 $ 2,286,213 [1] $ 7,175 183,250 (502,734) 2,583,923 14,599
Beginning balance (in shares) at Dec. 31, 2024 98,260 98,260        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) $ 54,489       54,429 60
Other comprehensive (loss)/income            
Translation gain/(loss) 175,839     175,864   (25)
Defined benefit plan adjustment, net of tax 544     544    
Derivative financial instruments, net of tax 1,757     1,757    
Other comprehensive (loss)/income 178,140     178,165   (25)
Divestiture of non-controlling interest (637)         (637)
Dividends (51,558)       (51,558)  
Dividends paid to noncontrolling interests (243)         (243)
Issuance of stock awards 273   273      
Issuance of stock awards (in shares)   588        
Shares repurchased (10,573)   (10,573)      
Shares repurchased (in shares)   (220)        
Share-based compensation 5,828   5,828      
Ending balance at Mar. 30, 2025 2,461,932 $ 7,175 178,778 (324,569) 2,586,794 13,754
Ending balance (in shares) at Mar. 30, 2025   98,628        
Beginning balance at Dec. 31, 2024 $ 2,286,213 [1] $ 7,175 183,250 (502,734) 2,583,923 14,599
Beginning balance (in shares) at Dec. 31, 2024 98,260 98,260        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) $ 670,753          
Other comprehensive (loss)/income            
Translation gain/(loss) 506,773          
Defined benefit plan adjustment, net of tax 4,176          
Derivative financial instruments, net of tax 2,169          
Other comprehensive (loss)/income 513,118     511,753    
Ending balance at Sep. 28, 2025 $ 3,319,516 $ 7,175 190,538 9,019 3,097,990 14,794
Ending balance (in shares) at Sep. 28, 2025 98,631 98,631        
Beginning balance at Mar. 30, 2025 $ 2,461,932 $ 7,175 178,778 (324,569) 2,586,794 13,754
Beginning balance (in shares) at Mar. 30, 2025   98,628        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 493,199       493,423 (224)
Other comprehensive (loss)/income            
Translation gain/(loss) 339,452     337,673   1,779
Defined benefit plan adjustment, net of tax 2,935     2,935    
Derivative financial instruments, net of tax 1,324     1,324    
Other comprehensive (loss)/income 343,711     341,932   1,779
Dividends (52,570)       (52,570)  
Issuance of stock awards 298   298      
Shares repurchased (3)   (3)      
Share-based compensation 4,145   4,145      
Other 121   121      
Ending balance at Jun. 29, 2025 3,250,833 $ 7,175 183,339 17,363 3,027,647 15,309
Ending balance (in shares) at Jun. 29, 2025   98,628        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 123,065       122,918 147
Other comprehensive (loss)/income            
Translation gain/(loss) (8,518)     (8,129)   (389)
Defined benefit plan adjustment, net of tax 697     697    
Derivative financial instruments, net of tax (912)     (912)    
Other comprehensive (loss)/income (8,733)     (8,344)   (389)
Divestiture of non-controlling interest (273)         (273)
Dividends (52,575)       (52,575)  
Issuance of stock awards 366   366      
Issuance of stock awards (in shares)   3        
Shares repurchased (4)   (4)      
Share-based compensation 6,775   6,775      
Other 62   62      
Ending balance at Sep. 28, 2025 $ 3,319,516 $ 7,175 $ 190,538 $ 9,019 $ 3,097,990 $ 14,794
Ending balance (in shares) at Sep. 28, 2025 98,631 98,631        
[1] The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (the “United States” or “U.S.”).